Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma
- PMID: 35533509
- DOI: 10.1016/j.oraloncology.2022.105901
Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma
Keywords: Biomarkers; Circulating microRNAs; Head and neck cancer; Liquid biopsy; Oral cancer; Plasma; Serum; miR-21.
Comment on
-
Reviewing the potential application of miR-21 inhibitors in oral cancer therapeutics.Oral Oncol. 2022 Feb;125:105713. doi: 10.1016/j.oraloncology.2022.105713. Epub 2022 Jan 15. Oral Oncol. 2022. PMID: 35042048 No abstract available.
-
Circulatory microRNAs inhibition and its signaling pathways in the treatment of oral squamous cell carcinoma (OSCC).Oral Oncol. 2022 Mar;126:105763. doi: 10.1016/j.oraloncology.2022.105763. Epub 2022 Feb 7. Oral Oncol. 2022. PMID: 35144207 No abstract available.
-
The Role of microRNAs as a predictive biomarker and therapeutic molecule in the treatment of Oral Potentially Malignant Disorder (OPMD).Oral Oncol. 2022 Apr;127:105786. doi: 10.1016/j.oraloncology.2022.105786. Epub 2022 Feb 26. Oral Oncol. 2022. PMID: 35231810 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical